KDM6B and neoplasm: Interestingly, expression of the PRC2 complex, which is a downstream target of pRB-E2F60,61 and MYCN28, was downregulated by KDM6B inhibition, in line with of the decrease of a number of H3K27me3 peaks and de-repression of a tumor suppressive program governed by EZH228.